Arkolith/Insider Trading/RCKT/Form 4

Shah Gaurav

CEO, DirectorROCKET PHARMACEUTICALS, INC. (RCKT) · full profile →Form 4 · filed Nov 20, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$19K
Net Open-Market Flow
-$19K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 18, 2025Sell(S)6K$2.98$19K778K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-25-042855) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML